Becton, Dickinson and Co. news

   Watch this stock
Showing stories 1 - 10 of about 99   

Articles published

BDX 145.03 -0.61 (-0.42%)
price chart
Becton, Dickinson and Co. (NYSE:BDX) a Hold: Canaccord Genuity
In a research note issued to investors, Jeffrey Frelick at Canaccord Genuity Reiterated their Hold rating on Becton, Dickinson and Co. (NYSE:BDX). The analyst placed a $149.00 price target on the stock which indicates a 3.02% upside to the last closing ...
Are These Stocks Showing The Right Potential? Becton, Dickinson and Co (BDX ...  GSPInsider
YieldBoost Becton, Dickinson and Co. From 1.6% To 7.3% Using Options
Shareholders of Becton, Dickinson and Co. (NYSE: BDX) looking to boost their income beyond the stock's 1.6% annualized dividend yield can sell the September covered call at the $150 strike and collect the premium based on the $4.00 bid, which ...
Becton Dickinson Said to Plan Asset Sales After CareFusion Deal
(Bloomberg) -- Becton, Dickinson & Co. is planning the sale of its respiratory-devices unit as it seeks to shed unwanted assets following its acquisition of CareFusion Corp.
Becton Dickinson & Co. (BDX) is Trading Lower on Unusual Volume for March 25
Latest Insights on Becton, Dickinson and Co. (NYSE:BDX)  Investor Newswire
Becton, Dickinson and Company to Commence Exchange Offers
FRANKLIN LAKES, N.J., March 26, 2015 /PRNewswire/ -- Becton, Dickinson and Company (NYSE: BDX) ("BD") announced today that it will commence offers to exchange all validly tendered and accepted notes of the following series issued by CareFusion ...
Why Leerink Is Upping Its Becton-Dickinson Target To $158
In a report published Friday, Leerink Partners analysts maintained a Market Perform rating on Becton, Dickinson and Company (NYSE: BDX), while raising the price target from $150 to $158, following the recent meeting with CEO Vincent Forlenza, CFO Chris ...
Analyst Consensus Price Target on Becton, Dickinson and Company (NYSE:BDX)  The Markets Daily
Weekly Investment Analysts' Ratings Updates for Becton, Dickinson and (BDX)  WKRB News
Becton Dickinson to buy CareFusion for $12 billion in cash, stock
(Reuters) - Medical equipment supplier Becton Dickinson & Co (BDX.N) has agreed to buy CareFusion Corp CFN.N, a maker of infusion pumps and other medical devices, for $12.2 billion in cash and stock, marking the latest multibillion-dollar healthcare ...
Becton Dickinson to buy CareFusion for US$12bil in cash, stock  The Star Online
Related articles »  
Becton Dickinson & Co
Becton Dickinson & Co was incorporated under the laws of the State of New Jersey in November 1906. The Company is a medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems an...mored ...
Moody's puts Becton Dickinson's ratings on review for downgrade following ...
New York, October 06, 2014 -- Moody's Investors Service placed Becton, Dickinson and Company's ("Becton's") A3 senior unsecured and Prime-2 ratings under review for downgrade following the company's announcement that it plans to acquire CareFusion ...
Related articles »  
Becton Dickinson & Co. (BDX) Falls 2.7% for March 06
Becton Dickinson & Co. is centered in Franklin Lakes, NJ, and has 30,619 employees. Today's trading day leaves the company with a market cap of $27.95 billionwith a P/E Ratio of 25.1. The company has a P/S ratio of 3.39, P/B ratio of 5.52, and a 62.6.
Becton, Dickinson and Co. to Issue Quarterly Dividend of $0.60 on March 31st ...  Mideast Time
Becton Dickinson & Co. (BDX) is Trading Higher on Unusual Volume for March 18
Becton Dickinson & Co. ($BDX) experienced unusually high volume on Mar. 18, as the stock gained 2.09% to a closing price of $144.51.
Becton Dickinson Completes Acquisition Of CareFusion  MarketWatch